Literature DB >> 15305573

NO and angiotensin II effects on blood pressure and fluid homeostasis.

H Liu1, M L Terrell, V Bui, J Y Summy-Long, M Kadekaro.   

Abstract

Angiotensin II (50 ng/5 microl) and L-NAME (250 microg/5 microl), an inhibitor of NO synthase (NOS), were administered intracerebroventricularly alone or in combination to conscious rats. Mean arterial blood pressure (MABP) increased reaching a peak within 5 min in all groups compared to controls treated with the vehicle, artificial CSF (5 microl). MABP returned to basal levels at 30 min after angiotensin II and remained stable for the following 90 min. In animals treated with L-NAME alone, after the initial pressor response, MABP declined but began to increase progressively from 30 min until the end of the experiment at 120 min. When administered with angiotensin II, however, the initial pressor response was prolonged. Angiotensin II-induced drinking was significantly attenuated by L-NAME. In control rats, inhibiting NOS elevated plasma levels of oxytocin and vasopressin but in angiotensin II-stimulated animals, only oxytocin was further elevated after L-NAME. Thus, NO formed centrally inhibits basal secretion of oxytocin and vasopressin as well as the resting blood pressure. During stimulation with angiotensin II, NO facilitates drinking, limits the pressor response and selectively inhibits oxytocin release.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 15305573     DOI: 10.1046/j.1365-2826.1997.00606.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  2 in total

1.  Nitric oxide and the oxytocin system in pregnancy.

Authors:  R Srisawat; M Ludwig; P M Bull; A J Douglas; J A Russell; G Leng
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

2.  Protective actions of estrogen on angiotensin II-induced hypertension: role of central nitric oxide.

Authors:  Baojian Xue; Minati Singh; Fang Guo; Meredith Hay; Alan Kim Johnson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-04       Impact factor: 4.733

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.